Compuware and SonarSource Unify Multi-Platform DevOps with Integrated COBOL Code Coverage Metrics
Mainframe-inclusive Continuous Code Quality Accelerates Digital Agility While De-Risking Generational Shift in Platform Stewardship
- To be digitally agile, enterprises must more quickly and frequently update their core mainframe systems-while also shifting stewardship of those applications from retiring COBOL veterans to IT staff with mainstream skills.
- Compuware has teamed with SonarSource to integrate accurate COBOL test coverage reporting into the automated QA processes they already use to support DevOps and Continuous Delivery.
- This new integration empowers large enterprises to dramatically accelerate mainframe application quality and throughput without incurring additional risk-even as they "mainstream" stewardship of those systems.
DETROIT, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Compuware and SonarSource today released new integrations that empower enterprise DevOps teams to accurately track and validate code coverage of COBOL application testing-with the same ease and employing the same processes-as they do with Java and other more mainstream code.
This ability to automate code coverage tracking across platforms is yet another example of how Compuware is empowering enterprise IT to apply the same proven and essential Agile, DevOps and Continuous Integration/Continuous Delivery (CI/CD) disciplines to both core systems of record and systems of engagement.
Code coverage metrics provide insight into the degree to which source code is executed during a test-that is, which lines of code have or have not been executed, and what percentage of an application has or has not been tested. These measurements allow IT teams to understand the scope and effectiveness of their testing as code is promoted towards production.
The new integrations automatically feed code coverage results captured by Compuware Topaz for Total Test into SonarSource SonarQube-a popular continuous code quality solution used by more than 900 digitally innovative enterprises-giving DevOps teams an accurate, unified view of quality metrics and milestones across platforms.
Continuous code quality management across platforms is of extraordinary value to large enterprises-since their ability to bring new digital deliverables to market is often contingent on simultaneously updating code across both back-end mainframe systems of record and front-end mobile/web systems of engagement.
More specifically, integration between Topaz for Total Test and SonarQube now enables DevOps teams to:
- Gain insight into the coverage of code being promoted for all application components across all platforms
- Improve the rigor of digital governance with strong enforcement of mainframe QA policies for coding errors, data leakage, credential vulnerabilities and more
- Shorten feedback loops to speed time-to-benefit and more promptly address shortfalls in COBOL skills and bottlenecks in mainframe DevOps processes
Topaz for Total Test captures code coverage metrics directly from the source code itself, rather than from a "source listing," as is the case with many outdated mainframe tools. This direct capture is more accurate and eliminates the need for development and test staff to understand the idiosyncrasies of how source listing models map to actual source code.
"Code coverage is such an integral part of continuous code quality that today's DevOps practitioners almost take it for granted," said Jason Bloomberg, President of agile digital transformation analyst firm Intellyx. "On the mainframe, however, code coverage has always been a difficult challenge. With today's announcement, Compuware and SonarSource bring mainframe code coverage into the DevOps era, further mainstreaming the mainframe."
"It is great that Compuware continues to develop a complete DevOps toolchain for COBOL. Adding code coverage is a major achievement and I am very happy this is happening," said Olivier Gaudin, CEO of SonarSource. "Our partnership with Compuware significantly enhances the ability of large enterprises to bring their mainframes into their cross-platform DevOps processes while still rigorously ensuring the quality of their core enterprise applications."
Compuware has also simplified the configuration and use of Xpediter Code Coverage-making it much easier for COBOL novices and experts alike to understand the effectiveness of their testing. When running automated tests and debugging code via Topaz's intuitive Eclipse interface, covered and uncovered code is highlighted so developers can quickly spot areas that need attention, just as they do in Java.
Today's announcement further delivers on Compuware's promise to mainstream the mainframe; that is, providing a familiar and intuitive mainframe development environment-integrated with state-of-the-art DevOps tools-for developers newly engaged as mainframe application stewards. The announcement marks the 13th consecutive quarter that Compuware has delivered significant innovation towards this modernization effort.
"Our customers run their businesses on the mainframe, so their proven COBOL applications are of extraordinary value and importance to them," said Chris O'Malley, CEO of Compuware. "That's why we are serving our customers by aggressively delivering the new solutions they need to achieve their ambitious goals for digital transformation, just like an authentic mainframe software partner should."
Compuware empowers the world's largest companies to excel in the digital economy by fully leveraging their high-value mainframe investments. We do this by delivering highly innovative solutions that uniquely enable IT professionals with mainstream skills to manage mainframe applications, data, and platform operations. Learn more at compuware.com.
Follow us on:
For Sales and Marketing Information
Compuware Corporation, One Campus Martius, Detroit MI 48226, 800-266-7892, www.compuware.com.
Copyright © 2018, Compuware Corporation. All rights reserved. The Compuware products and services listed within this release are trademarks or registered trademarks of Compuware Corporation.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Compuware Corporation via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
CORRECTION - Elite Petro & Gas broadens financial services and signs a deal with Tabarak Investment Capital Limited18.10.2018 23:35 | Pressemelding
DUBAI, United Arab Emirates, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Today the President of Elite Petro & Gas, Mr. George Matharu and the President of Tabarak Investment Capital Limited (Investment Bank), Dr. Mohamed Ahmadi announced a deal in which the two companies will use their combined resources to execute physical commodity trades, and provide banking and finance facilities for oil and gas transactions. The alliance between the two entities will also allow compliance related activities to be carried out from two major international hubs of London and Dubai. This increases the international presence of both companies. Additionally, Elite Petro & Gas (“EPG”) has recently formed relationships with the owners of a number of high profile European, South American and Chinese projects, which EPG and Tabarak can work on together. Tabarak Investment Capital Limited is a regulated investment bank by Dubai Financial Services Authority and incorporated in the Dubai International Financial Centre.
Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21 | Pressemelding
BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad
Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03 | Pressemelding
NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can
Meltwater and Dow Jones Announce Global Partnership to Provide Premium Content18.10.2018 14:00 | Pressemelding
SAN FRANCISCO and NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media intelligence, today announces the launch of a partnership with Dow Jones, a global provider of news and business information, to provide premium licensed content from Dow Jones Factiva into the Meltwater Media Intelligence platform. This partnership will give Meltwater’s PR and communications clients the ability to monitor and analyze premium licensed content across thousands of Factiva news sources globally, including: The Wall Street Journal, America’s largest newspaper by paid circulation; Barron’s; MarketWatch; and Dow Jones Newswires. “Meltwater provides our clients with the most comprehensive content network globally, across news, social media and broadcast media. This new Dow Jones partnership will further strengthen our leadership position and allow our clients to access licensed content from some of the most highly-respected news outlets in the world. We’re excited about this part
Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting18.10.2018 13:30 | Pressemelding
EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster session. Data to be presented across the Alzheimer’s disease clinical development portfolio, including aducanumab, BAN2401 and elenbecestat CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in Barcelona, Spain (October 24-27). The data being presented are part of Biogen’s ongoing research programs targeting possible causes of the disease through multiple modalities. “We are excited to engage with the scientific community at CTAD, to share learnings from our Alzheimer’s disease clinical research and to learn from the work of our colleagues around the world. We have hopes that our
SEMAFO Provides Notice of Third Quarter 2018 Results Release and Conference Call 18.10.2018 13:30 | Pressemelding
MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- SEMAFO (TSX, OMX: SMF) invites you to participate in a conference call on November 7, 2018 at 10:00 AM EST with senior management during which they will review the Corporation's third quarter 2018 financial and operational results. SEMAFO's financial statements and management's discussion and analysis for the third quarter 2018 will be released on November 6 after market hours and will be available in the “Investor Relations” section of the Corporation's website at www.semafo.com , and on the Canadian Securities Administrators' website at www.sedar.com . A live audio webcast of the conference call will be accessible for a period of 30 days through SEMAFO’s website at www.semafo.com . Tel. local & overseas: +1 (647) 788 4922 Tel. North America: 1 (877) 223 4471 Webcast: www.semafo.com Replay overseas: +1 (416) 621 4642 Replay N. America: 1 (800) 585 8367 Replay pass code: 2823689 Expiration: December 7, 2018 About SEMAFO SEMAFO is a Canadian-b
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom